Alex expresses an optimistic view on the rapid advancements in AI and their potential impact on epigenetic research, envisioning a future where technology accelerates breakthroughs. Meanwhile, Rebecca raises concerns about the lack of a clear leadership structure in a well-funded startup, suggesting that this could hinder their ability to scale effectively despite promising research findings.
